» Articles » PMID: 9469799

Structural Basis of Plasticity in T Cell Receptor Recognition of a Self Peptide-MHC Antigen

Overview
Journal Science
Specialty Science
Date 1998 Mar 21
PMID 9469799
Citations 201
Authors
Affiliations
Soon will be listed here.
Abstract

The T cell receptor (TCR) inherently has dual specificity. T cells must recognize self-antigens in the thymus during maturation and then discriminate between foreign pathogens in the periphery. A molecular basis for this cross-reactivity is elucidated by the crystal structure of the alloreactive 2C TCR bound to self peptide-major histocompatibility complex (pMHC) antigen H-2Kb-dEV8 refined against anisotropic 3.0 angstrom resolution x-ray data. The interface between peptide and TCR exhibits extremely poor shape complementarity, and the TCR beta chain complementarity-determining region 3 (CDR3) has minimal interaction with the dEV8 peptide. Large conformational changes in three of the TCR CDR loops are induced upon binding, providing a mechanism of structural plasticity to accommodate a variety of different peptide antigens. Extensive TCR interaction with the pMHC alpha helices suggests a generalized orientation that is mediated by the Valpha domain of the TCR and rationalizes how TCRs can effectively "scan" different peptides bound within a large, low-affinity MHC structural framework for those that provide the slight additional kinetic stabilization required for signaling.

Citing Articles

The Evolving T Cell Receptor Recognition Code: The Rules Are More Like Guidelines.

Gray G, Chukwuma P, Eldaly B, Perera W, Brambley C, Rosales T Immunol Rev. 2025; 329(1):e13439.

PMID: 39804137 PMC: 11771984. DOI: 10.1111/imr.13439.


design and structure of a peptide-centric TCR mimic binding module.

Householder K, Xiang X, Jude K, Deng A, Obenaus M, Wilson S bioRxiv. 2025; .

PMID: 39763827 PMC: 11702606. DOI: 10.1101/2024.12.16.628822.


Quantifying conformational changes in the TCR:pMHC-I binding interface.

McMaster B, Thorpe C, Rossjohn J, Deane C, Koohy H Front Immunol. 2024; 15:1491656.

PMID: 39687625 PMC: 11646856. DOI: 10.3389/fimmu.2024.1491656.


Artificial antigen-presenting cell system reveals CD28's role in modulating T cell functions during human immunodeficiency virus infection.

Kabakibo T, Arnold E, Padhan K, Lemieux A, Ortega-Delgado G, Routy J iScience. 2024; 27(10):110947.

PMID: 39381752 PMC: 11460474. DOI: 10.1016/j.isci.2024.110947.


Strategies and rules for tuning TCR-derived therapy.

Mo G, Lu X, Wu S, Zhu W Expert Rev Mol Med. 2023; 26:e4.

PMID: 38095091 PMC: 11062142. DOI: 10.1017/erm.2023.27.